Prognostic Role of Pre- and Post-Treatment [18F]FDG PET/CT in Squamous Cell Carcinoma of the Oropharynx in Patients Treated with Chemotherapy and Radiotherapy.

Détails

ID Serval
serval:BIB_6B93AE097ED6
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Prognostic Role of Pre- and Post-Treatment [18F]FDG PET/CT in Squamous Cell Carcinoma of the Oropharynx in Patients Treated with Chemotherapy and Radiotherapy.
Périodique
Medical sciences
Auteur⸱e⸱s
Dondi F., Gazzilli M., Albano D., Rizzo A., Treglia G., Pisani A.R., Palumbo C., Rubini D., Racca M., Rubini G., Bertagna F.
ISSN
2076-3271 (Electronic)
ISSN-L
2076-3271
Statut éditorial
Publié
Date de publication
29/07/2024
Peer-reviewed
Oui
Volume
12
Numéro
3
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
The prognostic role of imaging with [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) in oropharynx cancer (OPC) has been demonstrated in the past. The aim of this study was to assess the prognostic impact of both baseline and post-treatment PET/CT in patients with OPC and treated with chemo- and/or radiotherapy.
The PET/CT parameters of scans performed before and after therapy were collected and analyzed to find significant prognosticators for progression-free survival (PFS) and overall survival (OS). Human papillomavirus (HPV) infection's influence on the prognosis was also taken into account.
A total of 66 patients were included in the study. The staging volumetric parameters of PET/CT were significant prognosticators for OS, while the same parameters were affordable predictors for PFS at the restaging evaluation. No significant correlations between HPV infection and PET/CT parameters were reported.
The prognostic role of volumetric [18F]FDG PET/CT parameters in patients with OPC was reported.
Mots-clé
Humans, Fluorodeoxyglucose F18/therapeutic use, Positron Emission Tomography Computed Tomography, Male, Female, Middle Aged, Oropharyngeal Neoplasms/diagnostic imaging, Oropharyngeal Neoplasms/radiotherapy, Oropharyngeal Neoplasms/therapy, Prognosis, Aged, Adult, Carcinoma, Squamous Cell/diagnostic imaging, Carcinoma, Squamous Cell/therapy, Radiopharmaceuticals/therapeutic use, Chemoradiotherapy, Aged, 80 and over, Retrospective Studies, Papillomavirus Infections/complications, HPV, PET/CT, SCC, [18]F-FDG, head and neck, oropharynx, positron emission tomography, squamous cell carcinoma
Pubmed
Web of science
Open Access
Oui
Création de la notice
30/08/2024 15:14
Dernière modification de la notice
31/10/2024 7:13
Données d'usage